<DOC>
	<DOCNO>NCT03034096</DOCNO>
	<brief_summary>This large pragmatic multicenter trial compare maintenance general anesthesia total intravenous anesthesia use propofol versus volatile agent ( sevoflurane , isoflurane , desflurane ) cancer surgery . The primary endpoint all-cause mortality .</brief_summary>
	<brief_title>General Anesthetics CAncer REsection Surgery ( GA-CARES ) Trial</brief_title>
	<detailed_description />
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Anesthetics , General</mesh_term>
	<criteria>Patients know suspected cancer schedule undergo follow oncologic surgical procedure : Lobectomy pneumonectomy Esophagectomy Radical ( total ) cystectomy Pancreatectomy Partial hepatectomy Hyperthermic intraperitoneal chemotherapy ( HIPEC ) Gastrectomy ( subtotal total ) Cholecystectomy bile duct resection Age le 18 year American Society Anesthesiologist Class 5 Projected life expectancy le 30 day Known suspected hypersensitivity either propofol , e.g . egg soy allergy , volatile general anesthetic agent Known suspected history malignant hyperthermia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>